OVARIAN CANCER RECURRENT

This adverse event was reported 717 times

These drugs are most commonly taken by patients reporting OVARIAN CANCER RECURRENT:

# Drug Count
0 NIRAPARIB 131
1 CARBOPLATIN 130
2 OLAPARIB 109
3 PACLITAXEL 84
4 BEVACIZUMAB 72
5 GEMCITABINE HYDROCHLORIDE 49
6 GEMCITABINE 42
7 CISPLATIN 38
8 DOXORUBICIN HYDROCHLORIDE 23
9 TOPOTECAN 20
See all common drugs associated with OVARIAN CANCER RECURRENT